Latest Breaking News On - Curr med res - Page 1 : comparemela.com

AstraZeneca : SUPERNOVA Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19 in immunocompromised patient population - Form 6-K

A6269o FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Issuer Pursuant to Rule 13a-16 or.

Real-World Users of Triple Therapy for Asthma in the US

This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.

CDC's HICPAC Update: Impact on COVID-19, Pathogen Control, and Immunocompromised Safety in Health care Settings

Recent CDC HICPAC revisions regarding SARS-CoV-2 control face criticism from the World Health Network and others due to alleged breaches in committee structure and erroneous infection control guidance, potentially impacting COVID-19 management and immunocompromised individuals in health care.

喜讯！勃林格殷格翰罕见皮肤病新药圣利卓®拟定新适应症被纳入优先审评-美通社PR-Newswire

上海2023年6月30日 /美通社/ 6月29日 ，中国国家药品监督管理局（NMPA）药品审评中心（CDE）正式授予勃林格殷格翰罕见皮肤病创新靶向生物制剂圣利卓® （通用名：佩索利单抗注射液）用..

Janssen Submits Marketing Authorisation Application to the European Medicines Agency (EMA) Seeking Approval of Single Tablet Combination Therapy (STCT) of Macitentan and Tadalafil for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)